Exploring new strategies for the management of acute coronary syndromes (Q34084224)

30 July 2017

1 reference

title

Exploring new strategies for the management of acute coronary syndromes (English)

1 reference

30 July 2017

main subject

acute coronary syndrome

1 reference

Schwartz GG

1

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 October 2000

1 reference

American Journal of Cardiology

30 July 2017

published in

1 reference

30 July 2017

volume

86

1 reference

30 July 2017

issue

8B

1 reference

30 July 2017

page(s)

44J-49J; discussion 49J-50J

1 reference

Trends in the incidence of myocardial infarction and in mortality due to coronary heart disease, 1987 to 1994.

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901227-3

Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction. Results of the TIMI IIIB Trial. Thrombolysis in Myocardial Ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901227-3

Link between the angiographic substudy and mortality outcomes in a large randomized trial of myocardial reperfusion. Importance of early and complete infarct artery reperfusion. GUSTO-I Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901227-3

Toward a new frontier in myocardial reperfusion therapy: emerging platelet preeminence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901227-3

Combination therapy for acute myocardial infarction: fibrinolytic therapy and glycoprotein IIb/IIIa inhibition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901227-3

Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901227-3

Coronary angioplasty with or without stent implantation for acute myocardial infarction. Stent Primary Angioplasty in Myocardial Infarction Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901227-3

A randomized trial comparing primary angioplasty with a strategy of short-acting thrombolysis and immediate planned rescue angioplasty in acute myocardial infarction: the PACT trial. PACT investigators. Plasminogen-activator Angioplasty Compatibility

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901227-3

7 January 2021

Unstable angina pectoris

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901227-3

Outcomes in patients with acute non-Q-wave myocardial infarction randomly assigned to an invasive as compared with a conservative management strategy. Veterans Affairs Non-Q-Wave Infarction Strategies in Hospital (VANQWISH) Trial Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901227-3

Invasive versus conservative strategies in unstable angina and non-Q-wave myocardial infarction following treatment with tirofiban: rationale and study design of the international TACTICS-TIMI 18 Trial. Treat Angina with Aggrastat and determine Cost

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901227-3

Simvastatin preserves the ischemic-reperfused myocardium in normocholesterolemic rat hearts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901227-3

Tissue expression and immunolocalization of tumor necrosis factor-alpha in postinfarction dysfunctional myocardium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901227-3

Sodium ion/hydrogen ion exchange inhibition: a new pharmacologic approach to myocardial ischemia and reperfusion injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901227-3

Meeting highlights. Highlights of the 48th scientific sessions of the American College of Cardiology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901227-3

Increased glycolytic substrate protection improves ischemic cardiac dysfunction and reduces injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901227-3

Metabolic modulation of acute myocardial infarction. The ECLA (Estudios Cardiológicos Latinoamérica) Collaborative Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901227-3

Low-dose glucose-insulin-potassium is ineffective in acute myocardial infarction: results of a randomized multicenter Pol-GIK trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901227-3

Pyruvate dehydrogenase influences postischemic heart function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901227-3

Troglitazone improves recovery of left ventricular function after regional ischemia in pigs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901227-3

Emerging role of antibiotics in atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901227-3

Strategies to achieve coronary arterial plaque stabilization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901227-3

Effect of homocysteine-lowering treatment with folic acid plus vitamin B6 on progression of subclinical atherosclerosis: a randomised, placebo-controlled trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901227-3

Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901227-3

Hyperlipidemia and coronary disease. Correction of the increased thrombogenic potential with cholesterol reduction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901227-3

Molecular bases of the acute coronary syndromes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901227-3

HMG-CoA reductase inhibition by atorvastatin reduces neointimal inflammation in a rabbit model of atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901227-3

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901227-3

Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901227-3

Rationale and design of the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) study that evaluates atorvastatin in unstable angina pectoris and in non-Q-wave acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901227-3

10.1016/S0002-9149(00)01227-3

7 January 2021

Identifiers

DOI

1 reference

30 July 2017

1 reference